BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 7014063)

  • 1. Catabolin--a cartilage catabolic factor from synovium.
    Dingle JT
    Clin Orthop Relat Res; 1981 May; (156):219-31. PubMed ID: 7014063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of catabolin in the control of cartilage matrix integrity.
    Dingle JT
    J Rheumatol Suppl; 1983 Dec; 11():38-44. PubMed ID: 6583414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intercellular messengers in joint tissues in rheumatoid arthritis. How disturbed control mechanisms may contribute to tissue destruction and repair.
    Russell RG; McGuire MK; Meats JE; Ebsworth NM; Beresford J
    Scand J Rheumatol Suppl; 1981; 40():75-87. PubMed ID: 6100920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cellular interactions in joint erosions.
    Dingle JT
    Clin Orthop Relat Res; 1984; (182):24-30. PubMed ID: 6362945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody to interleukin 1 inhibits the cartilage degradative and thymocyte proliferative actions of rheumatoid synovial culture medium.
    Yodlowski ML; Hubbard JR; Kispert J; Keller K; Sledge CB; Steinberg JJ
    J Rheumatol; 1990 Dec; 17(12):1600-7. PubMed ID: 2084232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint.
    Cawston TE; Curry VA; Summers CA; Clark IM; Riley GP; Life PF; Spaull JR; Goldring MB; Koshy PJ; Rowan AD; Shingleton WD
    Arthritis Rheum; 1998 Oct; 41(10):1760-71. PubMed ID: 9778217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of catabolin by synovium from an experimental model of osteoarthritis.
    Sabiston CP; Adams ME
    J Orthop Res; 1989; 7(4):519-29. PubMed ID: 2786954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synovial factors and chondrocyte-mediated breakdown of cartilage: inhibition by hydrocortisone.
    Steinberg JJ; Sledge CB
    J Orthop Res; 1983; 1(1):13-21. PubMed ID: 6679571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
    Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of catabolin, the major product of pig synovial tissue that induces resorption of cartilage proteoglycan in vitro.
    Saklatvala J
    Biochem J; 1981 Dec; 199(3):705-14. PubMed ID: 7340826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes.
    Recklies AD; Baillargeon L; White C
    Arthritis Rheum; 1998 Jun; 41(6):997-1006. PubMed ID: 9627009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization and expression of cartilage oligomeric matrix protein by human rheumatoid and osteoarthritic synovium and cartilage.
    Di Cesare PE; Fang C; Leslie MP; Della Valle CJ; Gold JM; Tulli H; Perris R; Carlson CS
    J Orthop Res; 1999 May; 17(3):437-45. PubMed ID: 10376735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cytokines in arthritic diseases: in vitro and in vivo measurements of cartilage degradation.
    Dingle JT; Page Thomas DP; Hazleman B
    Int J Tissue React; 1987; 9(4):349-54. PubMed ID: 3497901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of extracellular matrix in osteoarthritis: 4 fundamental questions.
    Malemud CJ; Martel-Pelletier J; Pelletier JP
    J Rheumatol; 1987 May; 14 Spec No():20-2. PubMed ID: 3305934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic protein and transforming growth factor beta inhibitory Smads 6 and 7 are expressed in human adult normal and osteoarthritic cartilage in vivo and are differentially regulated in vitro by interleukin-1beta.
    Kaiser M; Haag J; Söder S; Bau B; Aigner T
    Arthritis Rheum; 2004 Nov; 50(11):3535-40. PubMed ID: 15529348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and pharmacological studies on synovium-cartilage interactions in organ culture.
    Crossley MJ; Hunneyball IM
    Eur J Rheumatol Inflamm; 1982; 5(1):15-29. PubMed ID: 7044793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synthetic processes of articular cartilage.
    Treadwell BV; Mankin HJ
    Clin Orthop Relat Res; 1986 Dec; (213):50-61. PubMed ID: 3536250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synovial cartilage interactions with special reference to the prostanoids as metabolic agents in cartilage under normal and pathological conditions.
    Mitrovic D
    Eur J Rheumatol Inflamm; 1982; 5(1):3-14. PubMed ID: 7044794
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.